Cadence Bank Takes $210,000 Position in National Health Investors, Inc. (NYSE:NHI)

Cadence Bank acquired a new stake in National Health Investors, Inc. (NYSE:NHI) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,500 shares of the real estate investment trust’s stock, valued at approximately $210,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of NHI. Assetmark Inc. raised its position in National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 141 shares during the period. Aviance Capital Partners LLC increased its position in shares of National Health Investors by 6.2% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,788 shares of the real estate investment trust’s stock worth $318,000 after purchasing an additional 221 shares during the last quarter. Arizona State Retirement System lifted its position in National Health Investors by 1.9% in the second quarter. Arizona State Retirement System now owns 12,152 shares of the real estate investment trust’s stock valued at $823,000 after buying an additional 222 shares during the last quarter. Covestor Ltd lifted its position in National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 405 shares during the last quarter. Finally, Van ECK Associates Corp boosted its stake in National Health Investors by 6.9% during the second quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust’s stock worth $434,000 after buying an additional 416 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Stock Performance

NYSE:NHI opened at $76.91 on Friday. The company has a market cap of $3.49 billion, a price-to-earnings ratio of 26.43, a price-to-earnings-growth ratio of 5.14 and a beta of 1.05. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 52 week low of $51.59 and a 52 week high of $86.13. The company has a fifty day simple moving average of $79.01 and a two-hundred day simple moving average of $74.68.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.08 EPS. As a group, equities analysts anticipate that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.68%. National Health Investors’s dividend payout ratio (DPR) is 123.71%.

Analysts Set New Price Targets

NHI has been the topic of a number of research analyst reports. Bank of America began coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Truist Financial increased their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and an average target price of $76.33.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.